Zobrazeno 1 - 10
of 76
pro vyhledávání: ''
Publikováno v:
Clinical Breast Cancer. 22:771-780
Considering old age and comorbidities, the actual benefit of chemotherapy in older patients with early triple-negative breast cancer (TNBC) remains uncertain. We aimed to select appropriate patients who could avoid chemotherapy in this population.A t
Publikováno v:
Clinical Breast Cancer. 22:e232-e238
Objective To evaluate factors contributing to positive surgical margins associated with reflector guidance for patients undergoing breast conserving therapy for malignancy. Materials and Methods A retrospective IRB-approved review of our institutiona
Publikováno v:
Clinical Breast Cancer. 21:e611-e617
Purpose : The breast-conserving surgery (BCS) rate of breast cancer patients in China is much lower than that in Europe and the United States. This study aims to identify factors affecting the choice of surgical modality following neoadjuvant chemoth
Publikováno v:
Clinical Breast Cancer. 21:e295-e301
Background With advances in treatment, outcomes for early-stage breast cancer are improving. We investigated the combination of prone position and deep inspiration breath hold to decrease cardiac doses for left-sided breast radiotherapy. Material and
Publikováno v:
Clinical Breast Cancer. 21:e448-e453
Background Breast conserving surgery (BCS) followed by radiotherapy is used for the management of early-stage breast cancers. There are different techniques to reconstruct the breast after BCS, each has its own advantages and disadvantages. In this s
Autor:
Giacomo Montagna, Monica Morrow
Publikováno v:
Clinical Breast Cancer. 21:112-119
Radiotherapy (RT) after breast-conserving surgery (BCS) halves the risk of local recurrence, and it is considered the standard of care for the vast majority of patients with early invasive breast cancer. However, the majority of patients treated with
Autor:
Julia Frebault, Carmen Bergom, Chandler S. Cortina, Monica E. Shukla, Yiwen Zhang, Chiang-Ching Huang, Amanda L. Kong
Publikováno v:
Clinical breast cancer. 22(6)
Despite an aging population, there are no established treatment guidelines for women with ductal carcinoma in situ (DCIS) age ≥80. Here we describe national treatment patterns and survival outcomes in older women with DCIS.Women age ≥80 diagnosed
Autor:
Cletus A. Arciero, J.Y. Lin, Neil T. Pfister, Mustafa Abugideiri, Pretesh Patel, Jeffrey M. Switchencko, Karen M. Xu, D. Zaenger, Walter J. Curran, Jane L. Meisel, Mylin A. Torres, Chase E. Escott, Preeti Subhedar
Publikováno v:
Clin Breast Cancer
Grade 3 disease was not well-represented in clinical trials investigating the omission of radiotherapy following breast conserving surgery in elderly women with early stage breast cancer. This Surveillance, Epidemiology, and End Results analysis of 1
Publikováno v:
Clinical Breast Cancer. 20:469-479
Whole breast radiation therapy (RT) has become standard of care in early stage breast cancer treatment following lumpectomy. Predictors of RT completion have been sparsely studied, with no previous nationwide examination of the impact of fractionatio
Autor:
Margaret M. Kozak, Frederick M. Dirbas, Emily Walck, Rie von Eyben, Clare E. Jacobson, Kathleen C. Horst, Paulina M. Gutkin
Publikováno v:
Clinical Breast Cancer. 20:431-438
Background Optimal surgical management of limited axillary nodal disease following neoadjuvant chemotherapy (NAC) for breast cancer is evolving. Concerns exist with respect to leaving residual disease in the axilla when omitting axillary lymph node d